Alzheimer's Disease: Neuroimaging

Alzheimer's disease (AD) is a chronic neurodegenerative disease. Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

July 1, 2020

Selective Neuronal Vulnerability in Alzheimer's Disease: A Network-Based Analysis

Neuron
Jean-Pierre RoussariePaul Greengard
July 1, 2020
Open Access

Therapeutic Angiogenesis with Sound Waves

Annals of Vascular Diseases
Tomohiko Shindo, Hiroaki Shimokawa
July 1, 2020

Evaluation of the neuroprotective effect of donepezil in type 2 diabetic rats

Fundamental & Clinical Pharmacology
Adel A GomaaMariam A Nicola
July 1, 2020
Review
Open Access

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders

Frontiers in Neuroscience
Emma M O'Connell, Falk W Lohoff
July 1, 2020
Open Access

A Machine Learning Approach for the Differential Diagnosis of Alzheimer and Vascular Dementia Fed by MRI Selected Features

Frontiers in Neuroinformatics
Gloria CastellazziClaudia A M Gandini Wheeler-Kingshott
July 1, 2020

Deciphering Alzheimer's disease: predicting new therapeutic strategies via improved understanding of biology and pathogenesis

Expert Opinion on Therapeutic Targets
Rita Khoury, George T Grossberg
July 2, 2020

A Reckoning to Keep Doing What We Are Already Doing With PET and SPECT Functional Neuroimaging

The American Journal of Psychiatry
Theodore A HendersonGiuseppe Cardaci
July 2, 2020

Pineal volume reduction in patients with mild cognitive impairment who converted to Alzheimer's disease

Psychiatry and Clinical Neurosciences
Teruyuki MatsuokaAlzheimer's Disease Neuroimaging Initiative
June 29, 2020
Preprint
Open Access

Population GNNs for Brain Age Prediction

BioRxiv : the Preprint Server for Biology
K. StankeviciuteP. Lio
July 2, 2020

Plasma proteomic signatures predict dementia and cognitive impairment

Alzheimer's & Dementia : Translational Research & Clinical Interventions
Toshiko TanakaLuigi Ferrucci
June 28, 2020

MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide

Brain : a Journal of Neurology
Vishnu M BashyamChristos Davatzikos
July 1, 2020

Clinical and Pathological Phenotypes of LRP10 Variant Carriers with Dementia

Journal of Alzheimer's Disease : JAD
Leonie J M VergouwVincenzo Bonifati
July 1, 2020

Spinocerebellar Ataxia-Like Presentation of the M233V PSEN1 Mutation

The Cerebellum
Yury SeliverstovSergey Illarioshkin
June 28, 2020
Open Access

Imaging the aging brain: study design and baseline findings of the SENIOR cohort

Alzheimer's Research & Therapy
Alexa HaegerSENIOR team

Sign up to follow this feed and discover related papers.

Related Feeds

AFM in situ DNA

AFM in situ DNA describes in situ analysis (or study) of DNA using atomic force microscopy. Discover the latest research on AFM in situ DNA here.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-neuroimaging/a5242adb-290c-4f90-bd45-b0d1bbfc9166